The path to true transparency
Sameer Awsare, MD, FACP, focuses on government rules and state laws attempting to hold pharmaceutical companies accountable to escalating prescription drug prices, and asks what's true transparency?
Sameer Awsare, MD, breaks down the basics of biosimilars
During a public briefing at the Alliance for Health Policy, Sameer Awsare, MD, of The Permanente Medical Group, joined other health care leaders to explain the mechanisms of biosimilar drugs.
Sameer Awsare, MD, Shares How High Drug Pricing Can Affect Patient Health
Rising health care costs are driving many policy conversations, and prescription drug pricing is no exception.